Conclusions

Stuart L. Silverman; Bo Abrahamsen

doi:10.1007/978-3-319-23639-1_23

Conclusions

Stuart L. Silverman
, Bo Abrahamsen^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til bog/antologi/rapport › Kapitel › Forskning › peer review

Abstract

We now have a diverse menu of osteoporosis therapies with proven efficacy in randomized clinical trials. As we individualize therapies for our patients, we need to base our decisions not only on efficacy but safety and adherence. However, this is challenging given that there are major limitations to the evidence base for long-term treatment and for use of drug holidays. This book and with its 23 chapters is a starting point for the clinician to understand the challenges of both short- and long-term safety concerns, adherence, and duration of therapies.

Originalsprog	Engelsk
Titel	The Duration and Safety of Osteoporosis Treatment
Undertitel	Anabolic and Antiresorptive Therapy
Forlag	Springer International Publishing AG
Sider	321-325
Antal sider	5
ISBN (Elektronisk)	9783319236391
ISBN (Trykt)	9783319236384
DOI	https://doi.org/10.1007/978-3-319-23639-1_23
Status	Udgivet - 1 jan. 2015

Adgang til dokumentet

10.1007/978-3-319-23639-1_23

Andre filer og links

https://www.scopus.com/pages/publications/85074311839

Citationsformater

@inbook{3aa370c2c7324a9fac37067dd6fa6ac5,

title = "Conclusions",

abstract = "We now have a diverse menu of osteoporosis therapies with proven efficacy in randomized clinical trials. As we individualize therapies for our patients, we need to base our decisions not only on efficacy but safety and adherence. However, this is challenging given that there are major limitations to the evidence base for long-term treatment and for use of drug holidays. This book and with its 23 chapters is a starting point for the clinician to understand the challenges of both short- and long-term safety concerns, adherence, and duration of therapies.",

keywords = "Anabolic medication, Antiresorptive medication, Atypical femoral fracture, Bisphosphonate holidays, ONJ, Osteoporosis, Osteoporosis medication safety",

author = "Silverman, \{Stuart L.\} and Bo Abrahamsen",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-23639-1\_23",

language = "English",

isbn = "9783319236384",

pages = "321--325",

booktitle = "The Duration and Safety of Osteoporosis Treatment",

publisher = "Springer International Publishing AG",

address = "Switzerland",

}

TY - CHAP

T1 - Conclusions

AU - Silverman, Stuart L.

AU - Abrahamsen, Bo

PY - 2015/1/1

Y1 - 2015/1/1

N2 - We now have a diverse menu of osteoporosis therapies with proven efficacy in randomized clinical trials. As we individualize therapies for our patients, we need to base our decisions not only on efficacy but safety and adherence. However, this is challenging given that there are major limitations to the evidence base for long-term treatment and for use of drug holidays. This book and with its 23 chapters is a starting point for the clinician to understand the challenges of both short- and long-term safety concerns, adherence, and duration of therapies.

AB - We now have a diverse menu of osteoporosis therapies with proven efficacy in randomized clinical trials. As we individualize therapies for our patients, we need to base our decisions not only on efficacy but safety and adherence. However, this is challenging given that there are major limitations to the evidence base for long-term treatment and for use of drug holidays. This book and with its 23 chapters is a starting point for the clinician to understand the challenges of both short- and long-term safety concerns, adherence, and duration of therapies.

KW - Anabolic medication

KW - Antiresorptive medication

KW - Atypical femoral fracture

KW - Bisphosphonate holidays

KW - ONJ

KW - Osteoporosis

KW - Osteoporosis medication safety

UR - https://www.scopus.com/pages/publications/85074311839

U2 - 10.1007/978-3-319-23639-1_23

DO - 10.1007/978-3-319-23639-1_23

M3 - Chapter

AN - SCOPUS:85074311839

SN - 9783319236384

SP - 321

EP - 325

BT - The Duration and Safety of Osteoporosis Treatment

PB - Springer International Publishing AG

ER -

Conclusions

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater